Translating MSC Therapy in the Age of Obesity

Mesenchymal stromal cell (MSC) therapy has seen increased attention as a possible option to treat a number of inflammatory conditions including COVID-19 acute respiratory distress syndrome (ARDS). As rates of obesity and metabolic disease continue to rise worldwide, increasing proportions of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Boland, Lauren, Bitterlich, Laura Melanie, Hogan, Andrew E., Ankrum, James A., English, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289617/
https://www.ncbi.nlm.nih.gov/pubmed/35860241
http://dx.doi.org/10.3389/fimmu.2022.943333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289617/
https://www.ncbi.nlm.nih.gov/pubmed/35860241
http://dx.doi.org/10.3389/fimmu.2022.943333

Ejemplares similares